Fermiscan Holdings Limited

Fermiscan Holdings Limited (Fermiscan) is a medical device company engaged in the development of products and technology for use in the detection and treatment of breast cancer. The company was formerly known as Olympus Resources Limited. The company is headquartered in Sydney, Australia.

The company operates through the Fermiscan Test which is the commercialisation of non-invasive and simple breast cancer screening for women. The company licenses and sells the test in the markets of Australia, Europe, Japan, South East Asia, and the US. In March 2009, it was granted exclusive option agreement to license the Fermiscan Test to Hitachi Chemical in Japan and Korea.

Street: 
Level 5
City: 
Sydney
Postcode: 
NSW 2000
Federal State : 
Australia
WebSite: 
www.fermiscan.com.au
Fax: 
61-2-92239622

Company Index Score

Current Index Score Historical Index Score
  • Fermiscan Holdings Limited currently scores 50 % in the index.
  • Fermiscan Holdings Limited is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Fermiscan Holdings Limited is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets